Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 94 entries
View as:

Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05348668 Org: User:
Start: 03/01/22 End: 05/01/25 Due: 05/01/26

Hypofraction Radiotherapy for Limited-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05523908 Org: User:
Start: 02/01/22 End: 08/01/24 Due: 08/01/25

Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT06462508 Org: User:
Start: 04/20/24 End: 12/31/25 Due: 12/31/26

Mesenteric Lymph Node Metastasis and Nutritional Status After Bowel Resection for Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06527001 Org: User:
Start: 06/16/24 End: 12/31/26 Due: 12/31/27

Differences in Brain Network Mechanisms Between STN and GPi Deep Brain Stimulation in the Treatment of Craniocervical Dystonia

Phase: N/A Priority: Normal
NCT ID: NCT06480188 Org: User:
Start: 03/01/24 End: 03/31/26 Due: 03/31/27

Radical Prostatectomy Without Prostate Biopsy Following PSMA PET/CT Based on Diagnostic Model

Phase: N/A Priority: Normal
NCT ID: NCT05587192 Org: User:
Start: 11/10/22 End: 06/30/24 Due: 06/30/25

Clinical Evaluation of Blood-Based Assays for Rapid Detection of Aβ Pathology in Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06889896 Org: User:
Start: 07/11/24 End: 08/01/25 Due: 08/01/26

Using Teach Back to Improve Postpartum Maternal-infant Health Among Women With Limited Maternal Health Literacy

Phase: N/A Priority: Normal
NCT ID: NCT04858945 Org: User:
Start: 05/17/21 End: 09/12/21 Due: 09/12/22

Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases

Phase: N/A Priority: Normal
NCT ID: NCT06294691 Org: User:
Start: 03/15/24 End: 08/31/26 Due: 08/31/27

Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab

Phase: N/A Priority: Normal
NCT ID: NCT06408584 Org: User:
Start: 03/01/24 End: 03/01/27 Due: 03/01/28

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research

Phase: N/A Priority: Normal
NCT ID: NCT06277011 Org: User:
Start: 02/10/23 End: 05/15/25 Due: 05/15/26

Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05269485 Org: User:
Start: 08/01/21 End: 12/01/24 Due: 12/01/25

To Evaluate the Clinical Study of CUD005 Injection in Patients With Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT06296095 Org: User:
Start: 08/09/23 End: 12/31/24 Due: 12/31/25

Oral Microbiome is Associated With the Response to Chemoradiotherapy in Initial Inoperable Patients With Esophageal Squamous Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06190847 Org: User:
Start: 07/01/23 End: 07/01/26 Due: 07/01/27

An Observational Study of Menopausal Symptom in Patients With Gynecological Malignancy After Oophorectomy

Phase: N/A Priority: Normal
NCT ID: NCT06151028 Org: User:
Start: 12/01/23 End: 12/31/33 Due: 12/31/34

The Effect of Frailty on Blood Biology Indicators, Quality of Life and Survival of Patients With Radical Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT05941104 Org: User:
Start: 07/15/23 End: 12/31/25 Due: 12/31/26

A Real-world Clinical Study of Pyrotinib Maleate Tablets in the Treatment of Breast Cancer Patients With Positive Her-2

Phase: N/A Priority: Normal
NCT ID: NCT03908749 Org: User:
Start: 04/10/19 End: 10/10/20 Due: 10/10/21

LISA vs INSURE in the Treatment of Respiratory Distress Syndrome in Preterm Infants

Phase: N/A Priority: Normal
NCT ID: NCT04126382 Org: User:
Start: 01/01/20 End: 12/31/24 Due: 12/31/25

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10- 19) in the Treatment of r/r B-ALL Clinical Research

Phase: N/A Priority: Normal
NCT ID: NCT05747157 Org: User:
Start: 02/15/23 End: 05/15/25 Due: 05/15/26

Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced Thrombocytopenia (CTIT) in the Treatment of Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06898983 Org: User:
Start: 03/31/25 End: 02/28/27 Due: 02/28/28

The Novel 18F-labeled MAO-B PET Tracer Study in Parkinsonism Patients

Phase: N/A Priority: Normal
NCT ID: NCT06010290 Org: User:
Start: 11/30/22 End: 12/31/23 Due: 12/31/24

Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT06973356 Org: User:
Start: 05/16/25 End: 06/30/29 Due: 06/30/30

SV2A-PET/CT and PET/MRI Combined Clinical Criteria Score in the Diagnosis of Early Cognitive Alteration

Phase: N/A Priority: Normal
NCT ID: NCT06445582 Org: User:
Start: 06/30/24 End: 12/31/25 Due: 12/31/26

Cervical Cancer Susceptible Population Classification

Phase: N/A Priority: Normal
NCT ID: NCT06405945 Org: User:
Start: 05/01/24 End: 06/30/36 Due: 06/30/37

A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites

Phase: N/A Priority: Normal
NCT ID: NCT06415500 Org: User:
Start: 05/06/24 End: 12/06/26 Due: 12/06/27